NCT01893359View on ClinicalTrials.gov

Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2016

Conditions
HyperopiaHyperopic Astigmatism
Interventions
DRUG

riboflavin ophthalmic solution, 0% dextran

DEVICE

UVA Irradiation (30 mW/cm2 for 2 minutes continuous UVA)

DEVICE

UVA Irradiation (30 mW/cm2 for 3 minutes pulsed UVA with an on/off cycle of 2 seconds UVA on/1 second UVA off)

PROCEDURE

Laser-assisted in situ keratomileusis

Trial Locations (5)

22102

See Clearly Vision, McLean

57108

Vance Thompson Vision, Sioux Falls

92122

Gordon -Weiss-Schanzlin Vision Institute, San Diego

02451

Ophthalmic Consultants of Boston, Waltham

07666

Hersh Vision Group, Teaneck

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY